Financial results - STRATEC BIOMEDICAL SRL

Financial Summary - Stratec Biomedical Srl
Unique identification code: 22971756
Registration number: J12/5493/2007
Nace: 6210
Sales - Ron
9.125.937
Net Profit - Ron
1.011.650
Employees
151
Open Account
Company Stratec Biomedical Srl with Fiscal Code 22971756 recorded a turnover of 2024 of 9.125.937, with a net profit of 1.011.650 and having an average number of employees of 151. The company operates in the field of Activităţi de realizare a soft-ului la comandă (software orientat client) having the NACE code 6210.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Stratec Biomedical Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 2.040.796 2.305.383 3.165.399 4.001.827 4.882.752 6.066.415 5.492.366 6.263.252 8.608.911 9.125.937
Total Income - EUR 2.480.439 2.432.601 3.325.768 4.244.012 5.670.679 7.111.015 6.299.752 6.783.386 8.589.689 9.389.897
Total Expenses - EUR 2.085.254 2.158.818 2.776.325 3.915.699 5.163.734 5.702.990 5.569.477 6.449.508 7.912.743 8.232.158
Gross Profit/Loss - EUR 395.185 273.784 549.444 328.313 506.944 1.408.025 730.275 333.878 676.946 1.157.739
Net Profit/Loss - EUR 340.122 227.815 442.221 276.181 427.221 1.199.489 636.195 280.310 573.110 1.011.650
Employees 49 58 87 107 130 141 134 136 145 151
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 6.6%, from 8.608.911 euro in the year 2023, to 9.125.937 euro in 2024. The Net Profit increased by 441.743 euro, from 573.110 euro in 2023, to 1.011.650 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Stratec Biomedical Srl

Rating financiar

Financial Rating -
STRATEC BIOMEDICAL SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Stratec Biomedical Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Stratec Biomedical Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Stratec Biomedical Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Stratec Biomedical Srl - CUI 22971756

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 699.167 3.266.136 3.392.405 3.054.544 2.894.663 2.717.460 2.615.397 2.594.311 5.066.042 4.664.142
Current Assets 1.201.588 765.759 1.130.292 1.687.670 2.138.773 3.269.407 3.579.825 4.065.468 1.912.711 2.726.824
Inventories 46.074 107.813 196.740 381.233 1.064.241 1.910.241 2.567.516 3.095.655 178.847 151.100
Receivables 254.389 105.564 358.971 140.115 501.405 509.013 225.972 869.206 659.439 925.442
Cash 901.125 552.382 574.582 1.166.322 573.127 850.154 786.336 100.608 1.074.425 1.650.282
Shareholders Funds 736.099 956.407 1.382.444 1.633.254 2.028.845 3.189.872 3.755.328 4.047.289 4.608.126 5.594.023
Social Capital 49.100 48.599 47.777 46.900 45.992 45.120 44.119 44.256 44.122 43.876
Debts 1.176.754 3.084.033 3.157.093 3.345.405 3.231.223 3.013.132 2.649.656 2.703.669 2.399.745 1.981.830
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "6210 - 6210"
CAEN Financial Year 6201
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.726.824 euro in 2024 which includes Inventories of 151.100 euro, Receivables of 925.442 euro and cash availability of 1.650.282 euro.
The company's Equity was valued at 5.594.023 euro, while total Liabilities amounted to 1.981.830 euro. Equity increased by 1.011.650 euro, from 4.608.126 euro in 2023, to 5.594.023 in 2024.

Risk Reports Prices

Reviews - Stratec Biomedical Srl

Comments - Stratec Biomedical Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.